Mymetics Corporation (MYMX)
Key Executives
Key Executives Information Not Available
Mymetics Corporation
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 2
Description
Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.
Corporate Governance
Recent Events
- Jan 02, 202415-12G: Notice of termination of registration of a class of securities under Section 12(g)See Full Filing
- Dec 28, 20238-K: Corporate Changes & Voting MattersSee Full Filing
- Dec 08, 2023S-8 POS: Offering RegistrationsSee Full Filing
- Nov 20, 202310-Q: Periodic Financial ReportsSee Full Filing
- Nov 15, 2023NT 10-Q: Periodic Financial ReportsSee Full Filing
Upcoming Events
Upcoming Events Information Not Available